图片展示
Search

Tang Huadong, Ph.D. CEO, Chairman,

作者:Shenox Pharmaceuticals LLC 浏览: 发表时间:2015-10-26 09:00:00

Dr. Tang serves as CEO of Shenox, which he co-founded in 2015. He also serves as chairman of GDB, which he founded in 2017 .


Dr. Tang is an expert in PK/PD and earned his PhD in Pharmaceutical sciences from the University of Arizona. He holds a bachelor degree in Microbiology from Fudan University. 


Dr. Tang worked in Wyeth, Schering Plough, Bristol-Myers Squibb for over than 10 years as a PK/PD expert. As a core member of the project team, he was responsible for drug metabolic dynamics and pharmacological research and development. His work covered a wide spectrum of activities from project initiation to post-clinical development and registration, in diverse therapeutic areas such as  diabetes, oncology, infections, and neuroscience.He was responsible for human pharmacokinetic/dose prediction and early clinical pharmacology in most project pharmacological assessments.


 A predictive clinical pharmacokinetic model (Tang's Coefficients; FCIM) was created that is widely used by the pharmaceutical academic and industrial communities. These models are important tools for evaluating the drug-made nature of new drugs and clinical pharmacological research.


He specializes in FDA communication, specializing in quantitative pharmacology (conversion, clinical), designing optimized and efficient 505b(2) paths. 


Recommended Pipeline

Recommended News

ADDRESS

 

1765 Greensboro Drive Suite 900, Tower 1 McLean, VA 22102

CONTACT

 

Mail:bd@shenoxpharma.com

添加微信好友,详细了解产品
使用企业微信
“扫一扫”加入群聊
复制成功
添加微信好友,详细了解产品
我知道了